Skip to main content Back to Top


Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution

Products Affected - Description

    • Flurox solution, OCuSOFT, 0.25%/0.4%, 5 mL bottle, 1 count, NDC 54799-0508-05

Reason for the Shortage

    • OCuSOFT has discontinued Flurox.
    • Altaire is the sole supplier of fluorescein/benoxinate ophthalmic solution.

Available Products

    • Altafluor solution, Altaire, 0.25%/0.4%, 5 mL bottle, 1 count, NDC 59390-0206-05

Estimated Resupply Dates

    • Altaire has Altafluor available.

Implications for Patient Care

    • Fluorescein/benoxinate and fluorescein/proparacaine ophthalmic solutions are combinations of a disclosing agent and a fast acting anesthetic that has a short duration of action

Alternative Agents & Management

    • Fluorescein/proparacaine ophthalmic solution is available.
    • Fluorescein/proparacaine and fluorescein/benoxinate areused in tonometry, corneal foreign body removal, suture removal, and other corneal or conjunctival procedures. They are dosed similarly for these indications.


Updated June 27, 2018 by Megan Dryer, PharmD. Created May 3, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.


Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins

ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.